Product Information
DIFLUNISAL 500 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $1.0427 per EA under NDC 62135045660. Its NADAC has been published 172 times since May 10, 2023.
FDA first approved this application on Mar 8, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Chartwell RX LLCNDC
62135045660
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DIFLUNISALApproval Type
Generic (ANDA)
FDA Application
ANDA202845FDA Approved
3/8/2012
TE Code
AB
On Market Since
3/8/2012
Pharmacological Classes
Price Statistics
The NADAC for DIFLUNISAL 500 MG TABLET has been published 172 times since May 10, 2023, and over the history we have for it it has risen 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0427 per EA |
|---|---|
| All-time high | $1.2455 (Apr 10, 2024) |
| All-time low | $0.8392 (Jan 22, 2025) |
| 52-week high | $1.1995 |
| 52-week low | $1.0380 |
| Median price | $1.0380 |
| Average price | $1.0516 |
| Largest weekly change | -25.6% (Nov 20, 2024) |
| Weeks tracked | 172 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DIFLUNISAL 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIFLUNISAL 500 MG TABLET, manufactured by Chartwell RX LLC, is $1.0427 per EA (NDC 62135045660), effective Aug 19, 2026.
How has the price of DIFLUNISAL 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIFLUNISAL 500 MG TABLET has risen 9.7%. It has been tracked across 172 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for DIFLUNISAL 500 MG TABLET?
Since May 10, 2023, the NADAC for DIFLUNISAL 500 MG TABLET has ranged from a low of $0.8392 (Jan 22, 2025) to a high of $1.2455 (Apr 10, 2024), with a median of $1.0380 per EA.
Are there cheaper alternatives to DIFLUNISAL 500 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DIFLUNISAL 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DIFLUNISAL 500 MG TABLET?
DIFLUNISAL 500 MG TABLET (NDC 62135045660) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.